Correspondence 0001104659-23-112243 from AVENUE THERAPEUTICS, INC. (ATXI) (CIK 0001644963) (ATXI)
AVENUE THERAPEUTICS, INC. (ATXI) (CIK 0001644963)
Date: Oct. 27, 2023 · CIK: 0001644963 · Accession: 0001104659-23-112243
AI Filing Summary & Sentiment
File numbers found in text: 333-274562
Letter
Re: Avenue Therapeutics, Inc.
October 27, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Registration Statement on Form S-1 (Reg. No. 333-274562)
Request for Acceleration of Effective Date
Ladies and Gentlemen:
As the underwriter of the proposed offering of Avenue Therapeutics, Inc. (the “Company”), we hereby withdraw our prior letter to join the acceleration request of the Company dated October 24, 2023 for the above-referenced Registration Statement.
Very
truly yours,
Maxim
Group LLC
Show Raw Text
CORRESP
1
filename1.htm
October 27, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Re:
Avenue Therapeutics, Inc.
Registration Statement on Form S-1 (Reg. No. 333-274562)
Request for Acceleration of Effective Date
Ladies and Gentlemen:
As
the underwriter of the proposed offering of Avenue Therapeutics, Inc. (the “Company”),
we hereby withdraw our prior letter to join the acceleration request of the Company dated October 24, 2023 for the above-referenced Registration
Statement.
Very
truly yours,
Maxim
Group LLC
By:
/s/
Clifford A. Teller
Name:
Clifford
A. Teller
Title:
Co-President